MétaCan
Menu
Back to cohort
Record W4385563490 · doi:10.1097/hep.0000000000000545

A global action agenda for turning the tide on fatty liver disease

2023· article· en· W4385563490 on OpenAlexafffund
Jeffrey V. Lazarus, Henry E. Mark, Alina M. Allen, Juan Pablo Arab, Patrizia Carrieri, Mazen Noureddin, William Alazawi, Naim Alkhouri, Saleh A. Alqahtani, Quentin M. Anstee, Marco Arrese, Ramón Bataller, Thomas Berg, Paul Brennan, Patrizia Burra, Graciela Castro‐Narro, Helena Cortez‐Pinto, Kenneth Cusi, Nikos Dedes, Ajay Duseja, Sven Francque, Amalia Gastaldelli, Hannes Hagström, Terry T.‐K. Huang, Dana Ivancovsky‐Wajcman, Achim Kautz, Christopher J. Kopka, Aleksander Krag, Philip N. Newsome, Mary E. Rinella, Diana Romero, Shiv Kumar Sarin, Marcelo Silva, C Wendy Spearman, Norah A. Terrault, Emmanuel Tsochatzis, Luca Valenti, Marcela Villota‐Rivas, Shira Zelber‐Sagi, Jörn M. Schattenberg, Vincent Wai‐Sun Wong, Zobair M. Younossi

Bibliographic record

VenueHepatology · 2023
Typearticle
Languageen
FieldMedicine
TopicLiver Disease Diagnosis and Treatment
Canadian institutionsLondon Health Sciences CentreWestern University
FundersFaculty of Medicine and Health, University of SydneyBirmingham Biomedical Research CentreFaculty of Medical Sciences, Newcastle UniversitySchool of Medicine, Shanghai Jiao Tong UniversityCollege of Medicine, King Saud UniversityMedical Research Councillékařská fakulta Univerzity KarlovySamsungUniversiti MalayaSirtex MedicalJulius ClinicalUniversitat de BarcelonaIpsenSun PharmaHouston Methodist Research InstituteFakultet Medicinskih Nauka, Univerziteta U KragujevcuNovo Nordisk FondenFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoUniversität LeipzigLinköpings UniversitetUniversiteit AntwerpenUniversity of KelaniyaUniversità degli Studi di PalermoShanghai Jiao Tong UniversityAllerganDanmarks GrundforskningsfondNovo NordiskCambridge University HospitalsSungkyunkwan UniversitySapienza Università di RomaKing Saud UniversityUniversity of OtagoSwedish Orphan BiovitrumAstellas PharmaKing Faisal Specialist Hospital and Research CentreMedpaceAin Shams UniversityInstitut National de la Santé et de la Recherche MédicalePontificia Universidad Católica de ChileEuropean Association for the Study of the LiverCanadian Association for the Study of the LiverNewcastle UniversityGenentechAstraZenecaNGM BiopharmaceuticalsGlaxoSmithKlineChiesi FarmaceuticiInselspital, Universitätsspital BernExelixisMongolian National University of Medical SciencesUniversidad de MálagaUniversity of BirminghamUniversity of Southern CaliforniaGilead SciencesSyddansk UniversitetPostgraduate Institute of Medical Education and Research, ChandigarhBristol-Myers SquibbCentres de Recerca de CatalunyaNovavaxNorgineUniversity Hospitals Birmingham NHS Foundation TrustCairo UniversityInnovationsfondenInstituto de Investigación Marqués de ValdecillaPfizerUniversity of WashingtonUniversità degli Studi di MilanoUniversidade Federal do Rio Grande do SulDr. Falk PharmaAlexion PharmaceuticalsUniversity of BernEli Lilly and CompanyUniversidade de LisboaGeneralitat de CatalunyaUniverzita Karlova v PrazeUniversity of DundeeChinese University of Hong KongNational Institutes of HealthHelwan UniversityCity University of New YorkKarolinska InstitutetYale UniversityMassachusetts General HospitalUniversity College LondonCilagAmgenCoherus BiosciencesFaculty of Medicine Siriraj Hospital, Mahidol UniversityCSL BehringSanofiEisaiUniversity of CambridgeAmerican Association for the Study of Liver DiseasesUniversidad de CádizOdense UniversitetshospitalShionogiFalk FoundationHospices Civils de LyonHouston Methodist HospitalUniversity of Cape TownImperial College LondonBarts CharityVlaamse regeringNational Research FoundationNational Institute for Health and Care ResearchQueen Mary University of LondonUniversity of HaifaFonds Wetenschappelijk OnderzoekLondon Health Sciences Centre
KeywordsAction (physics)Fatty liverPolitical scienceMedicineDiseaseInternal medicine

Abstract

fetched live from OpenAlex

BACKGROUND AND AIMS: Fatty liver disease is a major public health threat due to its very high prevalence and related morbidity and mortality. Focused and dedicated interventions are urgently needed to target disease prevention, treatment, and care. APPROACH AND RESULTS: We developed an aligned, prioritized action agenda for the global fatty liver disease community of practice. Following a Delphi methodology over 2 rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the action priorities using Qualtrics XM, indicating agreement using a 4-point Likert-scale and providing written feedback. Priorities were revised between rounds, and in R2, panelists also ranked the priorities within 6 domains: epidemiology, treatment and care, models of care, education and awareness, patient and community perspectives, and leadership and public health policy. The consensus fatty liver disease action agenda encompasses 29 priorities. In R2, the mean percentage of "agree" responses was 82.4%, with all individual priorities having at least a super-majority of agreement (> 66.7% "agree"). The highest-ranked action priorities included collaboration between liver specialists and primary care doctors on early diagnosis, action to address the needs of people living with multiple morbidities, and the incorporation of fatty liver disease into relevant non-communicable disease strategies and guidance. CONCLUSIONS: This consensus-driven multidisciplinary fatty liver disease action agenda developed by care providers, clinical researchers, and public health and policy experts provides a path to reduce the prevalence of fatty liver disease and improve health outcomes. To implement this agenda, concerted efforts will be needed at the global, regional, and national levels.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.042
Threshold uncertainty score0.406

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.092
GPT teacher head0.362
Teacher spread0.270 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations90
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueHepatologySame topicLiver Disease Diagnosis and TreatmentFrench-language works237,207